Browsing Tag
YUFLYMA
2 posts
Celltrion’s YUFLYMA gains full FDA interchangeability: What it means for U.S. biosimilar market
Discover how Celltrion’s YUFLYMA earned full FDA interchangeability, boosting biosimilar adoption and reshaping the U.S. immunology drug market.
Celltrion USA announces availability of adalimumab-aaty with 85% discount
In a bold move to reshape the pharmaceutical landscape, Celltrion USA has announced the availability of its high-concentration,…